“Frailty” in patients with Parkinsonian Spectrum Disorders: an observation from a tertiary care teaching hospital
DOI:
https://doi.org/10.31117/neuroscirn.v7i4.319Keywords:
Frailty, Modified frailty index, Idiopathic Parkinson's disease, Multisystem atrophy, Progressive supranuclear palsyAbstract
Patients with movement disorders are in a pre-frail state due to the physical limitation or reduction in tolerance to physical stress. The study was conducted in the Department of Neurology of a tertiary care teaching hospital in Northern-east Rajasthan with 50 patients. Inclusion criteria: patients with parkinsonian features aged >18 years; and willing to give consent regarding participation in the study. Exclusion criteria: patients with age <18 years; not willing to participate in the study; and exclusion of alternative diagnosis. Frailty and pre-frailty states were assessed using the Fried’s criteria. Modified Frailty Index (MFI) was used to classify it as mild, moderate, and severe. Unified Parkinson's Disease Rating Scale (UPDRS), Multisystem Atrophy Rating Scale (MSARS), and Progressive Supranuclear Palsy Rating Scale (PSPRS) were used for respective disorders. The data was compiled using an MS Excel sheet, and SPSS 20 was used for statistical analysis. Thirty-nine patients fulfilled the criteria for “frailty-phenotype”; only 9 were “pre-frail”, and 2 were non-frail. On the MFI, patients with atypical parkinsonism had severe frailty with a mean index score of 0.54, where the mean scores were higher in the progressive supranuclear palsy (PSP) group (0.57) than in the multisystem atrophy (MSA) group (0.5). Patients with idiopathic Parkinson’s disease (IPD) had mild to moderate frailty with a mean score of 0.29 (Range 0.17-0.51). With a higher UPDRS score, the frailty index score in IPD patients was also higher, as was PSPRS in patients with PSP and UMSARS in patients with MSA. The mean MMSE score was also lower in the group with a higher frailty index. The levodopa dose requirement was higher in the frail group than in the non-frail or prefrail group (125mg/day vs. 625mg/day; p<0.05). Frailty is part and parcel of neurodegenerative movement disorders, including movement disorders, and adds to the burden of disease.
References
Acharya, M., Banerjee, S., Chatterjee, A., Mukherjee, A., Biswas, S., Gangopadhyay, G., & Biswas, A. (2021). Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test. Neurology India, 69(2), 430–434. https://doi.org/10.4103/0028-3886.314539
Ahmed, N. N., Sherman, S. J., & VanWyck, D. (2008). Frailty in Parkinson’s disease and its clinical implications. Parkinsonism & Related Disorders, 14(4), 334–337. https://doi.org/10.1016/J.PARKRELDIS.2007.10.004
Amaral, C. A., Amaral, T. L. M., Monteiro, G. T. R., Vasconcellos, M. T. L., & Portela, M. C. (2019). Hand grip strength: Reference values for adults and elderly people of Rio Branco, Acre, Brazil. PLoS ONE, 14(1), e0211452. https://doi.org/10.1371/JOURNAL.PONE.0211452
Belvisi, D., Canevelli, M., Costanzo, M., Giangrosso, M., Fabbrini, A., Borraccino, A., Bruno, G., Berardelli, A., & Fabbrini, G. (2022). The role of frailty in Parkinson’s disease: a cross-sectional study. Journal of Neurology, 269(6), 3006–3014. https://doi.org/10.1007/S00415-021-10873-3
Clegg, A., Bates, C., Young, J., Ryan, R., Nichols, L., Ann Teale, E., Mohammed, M. A., Parry, J., & Marshall, T. (2016). Development and validation of an electronic frailty index using routine primary care electronic health record data. Age and Ageing, 45(3), 353–360. https://doi.org/10.1093/AGEING/AFW039
Constantinescu, R., Richard, I., & Kurlan, R. (2007). Levodopa responsiveness in disorders with parkinsonism: A review of the literature. Movement Disorders, 22(15), 2141–2148. https://doi.org/10.1002/MDS.21578
Degirmenci, Y., Angelopoulou, E., Georgakopoulou, V. E., & Bougea, A. (2023). Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches. Medicina, 59(10), 1756. https://doi.org/10.3390/MEDICINA59101756
Ebina, J., Ebihara, S., & Kano, O. (2022). Similarities, differences and overlaps between frailty and Parkinson’s disease. Geriatrics & Gerontology International, 22(4), 259–270. https://doi.org/10.1111/GGI.14362
Farhat, J. S., Velanovich, V., Falvo, A. J., Horst, H. M., Swartz, A., Patton, J. H., & Rubinfeld, I. S. (2012). Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly. Journal of Trauma and Acute Care Surgery, 72(6), 1526–1531. https://doi.org/10.1097/TA.0B013E3182542FAB
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., & McBurnie, M. A. (2001). Frailty in older adults: evidence for a phenotype. The Journals of Gerontology, 56(3), M146–M157. https://doi.org/10.1093/GERONA/56.3.M146
Lin, W. C., Huang, Y. C., Leong, C. P., Chen, M. H., Chen, H. L., Tsai, N. W., Tso, H. H., Chen, P. C., & Lu, C. H. (2019). Associations Between Cognitive Functions and Physical Frailty in Patients with Parkinson’s Disease. Frontiers in Aging Neuroscience, 11, 283. https://doi.org/10.3389/FNAGI.2019.00283/BIBTEX
McMillan, J. M., Michalchuk, Q., & Goodarzi, Z. (2021). Frailty in Parkinson’s disease: A systematic review and meta-analysis. Clinical Parkinsonism & Related Disorders, 4, 100095. https://doi.org/10.1016/J.PRDOA.2021.100095
Mitra, K., Gangopadhaya, P., & Das, S. (2003). Parkinsonism plus syndrome - A review. Neurology India, 51(2), 183–188.
Raimo, S., Gaita, M., Cropano, M., Mautone, G., D’Iorio, A., Trojano, L., & Santangelo, G. (2022). The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis. Neuropsychology Review, 33(2), 514–543. https://doi.org/10.1007/S11065-022-09551-6
Rockwood, K., Song, X., MacKnight, C., Bergman, H., Hogan, D. B., McDowell, I., & Mitnitski, A. (2005). A global clinical measure of fitness and frailty in elderly people. Canadian Medical Association Journal, 173(5), 489–495. https://doi.org/10.1503/CMAJ.050051
Shin, H. W., Hong, S. W., & Youn, Y. C. (2022). Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism. Journal of Clinical Neurology, 18(3), 259–270. https://doi.org/10.3988/JCN.2022.18.3.259
Simon, D. K., Tanner, C. M., & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36(1), 1–12. https://doi.org/10.1016/J.CGER.2019.08.002
Smith, N., Gaunt, D. M., Whone, A., Ben-Shlomo, Y., & Henderson, E. J. (2021). The Association Between Frailty and Parkinson’s Disease in the ReSPOnD Trial. Canadian Geriatrics Journal, 24(1), 22–25. https://doi.org/10.5770/CGJ.24.437
Tiwari, S. C., Tripathi, R. K., & Kumar, A. (2009). Applicability of the Mini-mental State Examination (MMSE) and the Hindi Mental State Examination (HMSE) to the urban elderly in India: a pilot study. International Psychogeriatrics, 21(1), 123–128. https://doi.org/10.1017/S1041610208007916
Xue, Q. L. (2011). The Frailty Syndrome: Definition and Natural History. Clinics in Geriatric Medicine, 27(1), 1–15. https://doi.org/10.1016/j.cger.2010.08.009
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Himanshu Kaushal, Rajendra Kumar Sureka, Amit Kumar Agarwal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The observations and associated materials published or posted by NeurosciRN are licensed by the authors for use and distribution in accord with the Creative Commons Attribution license CC BY-NC 4.0 international, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
